NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Financial Conflicts of
Interest Policy
Contact the NSABP
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-51
Protocol B-52
Protocol B-53/S1207
Protocol B-55/BIG 6-13
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol C-04
A Clinical Trial to Assess the Relative Efficacy of 5-FU + Leucovorin, 5-FU + Levamisole, and 5-FU + Leucovorin + Levamisole in Patients with Dukes' B and C Carcinoma of the Colon
Specific Aims
In patients who have undergone a "curative" resection of a Dukes' B or C carcinoma of the colon, to determine if the addition of levamisole to leucovorin-modulated 5-FU provides an additional benefit in regard to disease-free survival and survival and, if so, to assess whether this benefit is superior to that achieved by administration of 5-FU + levamisole. The study will also evaluate whether 5-FU administered with levamisole is superior to leucovorin-modulated 5-FU.
